OTCMKTS:PTNT Palatin Technologies (PTNT) Stock Price, News & Analysis $26.09 +0.15 (+0.58%) As of 06/26/2026 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesInsider TradesSEC FilingsBuy This Stock About Palatin Technologies Stock (OTCMKTS:PTNT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Palatin Technologies alerts:Sign Up Key Stats Today's Range$26.09▼$26.0950-Day Range$8.53▼$28.0652-Week Range$25.28▼$28.06Volume209 shsAverage Volume1,817 shsMarket Capitalization$25.39 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. The company was founded in 1986 and is based in Cranbury, New Jersey. Read More Receive PTNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Palatin Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PTNT Stock News HeadlinesPalatin Technologies (OTCMKTS:PTNT) Stock Passes Above 200 Day Moving Average - Here's WhyJune 26 at 3:06 AM | americanbankingnews.comPalatin Technologies Is Pursuing the Next Generation of MC4R. Rhythm Just Reinforced Why That MattersJune 18, 2026 | theglobeandmail.comTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.June 27 at 1:00 AM | Altimetry (Ad)Palatin Technologies (OTCMKTS:PTNT) Stock Crosses Above 200 Day Moving Average - Here's WhyJune 18, 2026 | americanbankingnews.comPalatin Technologies Voluntarily Transfers Stock Listing to NasdaqMay 19, 2026 | theglobeandmail.comPalatin Technologies, Inc.: Palatin to Begin Trading on Nasdaq Stock ExchangeMay 19, 2026 | finanznachrichten.dePalatin Technologies Inc (PTN) Q2 2026 Earnings Call Highlights: Strategic Advances Amid Rising ...February 17, 2026 | finance.yahoo.comPalatin Technologies, Inc.: Palatin Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate UpdateFebruary 17, 2026 | finanznachrichten.deSee More Headlines PTNT Stock Analysis - Frequently Asked Questions How have PTNT shares performed this year? Palatin Technologies' stock was trading at $5.60 on January 1st, 2026. Since then, PTNT stock has increased by 365.9% and is now trading at $26.09. How were Palatin Technologies' earnings last quarter? Palatin Technologies, Inc. (OTCMKTS:PTNT) released its earnings results on Wednesday, May, 15th. The biopharmaceutical company reported ($26.50) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($25.00) by $1.50. Read the conference call transcript. When did Palatin Technologies' stock split? Shares of Palatin Technologies reverse split on Tuesday, August 12th 2025.The 1-50 reverse split was announced on Tuesday, August 12th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, August 12th 2025. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. How do I buy shares of Palatin Technologies? Shares of PTNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/15/2024Today6/27/2026Fiscal Year End6/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:PTNT Previous SymbolPINK:PTNT CIK911216 Webwww.palatin.com Phone(609) 495-2200Fax609-495-2202Employees30Year FoundedN/AProfitability EPS (Trailing Twelve Months)($60.00) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$29.74 million Net MarginsN/A Pretax Margin-1,590.66% Return on EquityN/A Return on Assets-365.57% Debt Debt-to-Equity RatioN/A Current Ratio0.38 Quick Ratio0.38 Sales & Book Value Annual Sales$4.49 million Price / Sales5.65 Cash FlowN/A Price / Cash FlowN/A Book Value($0.25) per share Price / Book-104.36Miscellaneous Outstanding Shares973,000Free Float18,160,000Market Cap$25.39 million OptionableNot Optionable Beta0.75 The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (OTCMKTS:PTNT) was last updated on 6/27/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredSpaceX is offering you shares. Don't take them.SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. At a $...Behind the Markets | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palatin Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Palatin Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PTNT Stock Alerts